Edition:
United Kingdom

Clovis Oncology Inc (CLVS.OQ)

CLVS.OQ on NASDAQ Stock Exchange Global Select Market

10.95USD
19 Jul 2019
Change (% chg)

$-0.62 (-5.36%)
Prev Close
$11.57
Open
$11.66
Day's High
$11.70
Day's Low
$10.70
Volume
975,633
Avg. Vol
515,308
52-wk High
$48.25
52-wk Low
$10.70

About

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $4,124.93
Shares Outstanding(Mil.): 48.88
Dividend: --
Yield (%): --

Financials

  CLVS.OQ Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -8.75 -- --
ROI: -72.20 8.94 14.49
ROE: -162.18 10.07 15.79

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

12 Apr 2019

Clovis Oncology halts mid-stage bladder cancer trial, shares drop

April 12 Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its lead drug in bladder cancer patients, sending shares down 12 percent.

12 Apr 2019

Earnings vs. Estimates